×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Bellerophon Therapeutics (BLPH) Dips More Than Broader Markets: What You Should Know
Yahoo Movies Canada
Bellerophon Therapeutics (BLPH) closed the most recent trading day at $9.92, moving -0.6% from the previous trading session.
3 days ago
Bellerophon Therapeutics (OTCPK:BLPH) - Stock Price, News & Analysis
Simply Wall Street
Research Bellerophon Therapeutics' (OTCPK:BLPH) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth,...
6 months ago
Bellerophon whittles workforce, discontinues device development
Fierce Biotech
Though its eponym in Greek mythology was able to successfully defeat the fire-breathing chimera, Bellerophon Therapeutics' story is closing...
10 months ago
Bellerophon Shareholders Vote to Dissolve Amid Board Resignations - TipRanks.com
Tipranks
Bellerophon (BLPH) just unveiled an update. Bellerophon Therapeutics, Inc. is set to dissolve after a decisive shareholder vote favored the...
2 months ago
Bellerophon Therapeutics (BLPH) Reports Q3 Loss, Lags Revenue Estimates
Yahoo News UK
Bellerophon Therapeutics (BLPH) delivered earnings and revenue surprises of -2.44% and -100.00%, respectively, for the quarter ended...
2 days ago
Bellerophon's study of fILD therapy fails to meet primary endpoint
Clinical Trials Arena
Bellerophon Therapeutics has reported that its Phase III trial of INOpulse for interstitial lung disease failed to meet its primary...
11 months ago
Bellerophon Therapeutics (NASDAQ:BLPH) Receives New Coverage from Analysts at StockNews.com
Defense World
Read Bellerophon Therapeutics (NASDAQ:BLPH) Receives New Coverage from Analysts at StockNews.com at Defense World.
1 week ago
Hilco Streambank Seeks Offers to Acquire Patent Portfolio and Material Inventory of Biotherapeutics Company ...
PR Newswire
PRNewswire/ -- Hilco Streambank (www.HilcoStreambank.com), a leading intellectual property advisory firm specializing in the valuation and...
5 months ago
Bellerophon trial fails despite innovative digital endpoint
STAT
Bellerophon is abandoning a Phase 3 trial of its pulmonary fibrosis treatment after patients using a digital endpoint showed no improvement.
11 months ago
Why Is Bellerophon Therapeutics (BLPH) Stock Down 34% Today?
InvestorPlace
Bellerophon Therapeutics (BLPH) stock is losing value on Tuesday after the clinical-stage therapeutics company was sent a delisting notice.
9 months ago